Which experimental model to choose to study arterial thrombosis and evaluate potentially useful therapeutics?

Pathophysiology of Haemostasis and Thrombosis

Volumn 26, Issue , 1996, Pages 55-69

  Andre, Patrick ^a   Dit Sollier, Claire Bal ^a   Bonneau, Michel ^a   Pignaud, George ^a   Hainaud, Patricia ^a   Azzam, Kalid ^a   Drouet, Ludovic ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Animal models; Anticoagulant; Antiplatelet agent; Arterial thrombosis; Experimental thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ANIMAL MODEL; ARTERY THROMBOSIS; CONFERENCE PAPER; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARTERIOSCLEROSIS; ARTIFACTS; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; DISEASE MODELS, ANIMAL; DOGS; DRUG EVALUATION, PRECLINICAL; ENDOTHELIUM, VASCULAR; FIBRINOLYTIC AGENTS; HEMORHEOLOGY; HUMANS; LASERS; PAPIO; PERFUSION; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SPECIES SPECIFICITY; SWINE; THROMBOLYTIC THERAPY; THROMBOSIS;

EID: 0029944888     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000217286     Document Type: Article

References (58)

1. Burke SE. Lefer AM, Nicolaou KC. Smith GM. Smith B. Responsiveness of platelets and coro nary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues. Br J Pharmacol. 1983;78:287-292.
2. Kupinski JM, Miller JL. Identification of receptors for fibrinogen and von Willebrand factor mediating aggregation in guinea pig platelets. Thromb Res. 1986;43:335-344.
3. Kupinski JM. Miller JL. Synthesis by guinea pig megakaryocytes of platelet glycoprotein receptors for fibrinogen and von Willebrand factor. Thromb Res. 1986;43:345-352.
4. André P, Hainaud P. Bal dit Sollier C. Drouet V. Garfinkel LI. Uzan A. Caen JP. Drouet LO. Guinea pig blood: a model for the pharmacological modulation of the GPIb/IX-vWF axis. Thromb Res. 1996 Accepted.
5. Levin J. Why are recently published platelet counts in normal mice so low ? Blood 1994:83:3829-3830.
6. Hardhammar PA, van Beusekom HM, Emanuelson HU, Hofma SH, Albertsson PA, Verdouw PD. Boersma E, Serruys PW. van der Giessen WJ. Reduction in thrombotic events with heparin coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 1996;93:423-430.
7. Dicgucz G. Garcia AP. Condc MV, Gomez B. Santa Maria L, Lluch S. In vitro studies of the carotid rete mirabile of arteriodactyla. Microvasc. Res. 1987;33:143-154.
8. Bailliart O. Bonneau M. Bonnin P. Pignaud G, Drouet L. L’hémodynamique des territoires vas culaires du porc est-elle comparable à celle de l’homme ? in Le porc: modèle de pathologie vasculaire humaine. (Eds A. Aumaitre, L. Drouet, C. Bal dit Sollier) Editions scientifiques de l'INRA. Paris, 1995.
9. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J. 1983:50:127-134.
10. Van der Wal AC, Becker AE, Van der Loos CM, Das PK. Site of intimai rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology see comments Circulation 1994;89:36-44.
11. Hasler-Rapacz J, Prescott MF. Von Linden-Reed J. Rapacz JM Jr, Hu Z, Rapacz J. Elevated concentrations of plasma lipids and apolipoproteins B, C-11I. and E are associated with the progression of coronary artery disease in familial hypercholesterolemic swine. Arterioscl. Thromb. Vase. Biol. 1995;15:583-592
12. Folts JD. Gallagher K. Rowe GG. Blood How reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation? Circulation. 1982;65:248-255.
13. Folts JD. Effect of length of coronary artery stenosis on the production of acute platelet thrombi. Fed Proc. 1983:42:4595A.
14. Folts JD. An in-vivo model of experimental arterial stenosis, intimai damage and periodic thrombosis. Circulation. 1991:83 suppl. V:3-14.
15. Frederick LG. Suleymanov OD. King LW. Salyers AK. Nicholson NS. Feigen LP. The protective dose of the potent GPllb/IIIa antagonist SC-54701 A is reduced when used in combination with aspirin and heparin in a canine model of coronary artery thrombosis. Circulation. 1996:93:129-134.
16. Nichols TC. Bellinger DA. Johnson TA, Lamb MA, Griggs TR. Von Willebrand's disease prevents occlusive thrombosis in stenosed and injured porcine coronary arteries. Circ. Res. 1986:59:15-26.
17. Samama CM, Bonneau M, Bailliart O, Pignaud G, Scrobohaci ML. Caen JP, Viars P, Drouet L. O. Absence of side effects of Hydroxyethylstarch 200 in a porcine model of experimental arterial thrombosis. Thromb Res. 1991:65:691-698.
18. Samama CM, Bonnin P. Bonneau M. Pignaud G. Mazoyer E. Bailliart O. Maffrand JP. Viars P. Caen JP. Drouet LO. Comparative arterial antithrombotic activity of Clopidogrel and acetyl salicylic acid in the pig. Thromb Haemostas. 1992:68:500-505.
19. McBane RD. Wysokinski WE, Chesebro JH, Owen WG. Antithrombotic action of endogenous porcine protein C activated with a latent porcine thrombin preparation. Thromb Haemost. 1995 Sep;74(3):879-885.
20. Alig L. Edenhofer A, Hadvary P, Huerzeler M. Knopp D. Mueller M, Steiner B, Trzeciak A, Weller T. Low molecular weight, non-peptidic fibrinogen receptor antagonists. J. Med. Chem. 1992:35:4393-4407.
21. Andersen H.R. Maeng M. Thorwest M. Falk E. Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury. Circulation 1996; 93: 1716-1724.
22. André P. Brouland JP. Bailliart O, Bonneau M. Pignaud G. Bonnin P. Roussi J. Bal dit Sollier C. Drouet LO. Long term prevention of the intraluminal extension of a parietal thrombus by a GPIlb/IIla inhibitor in a pig thrombosis model. Submitted to J Pharmacol. Exp. Therap. 1996.
23. Golino P. Ambrosio G, Pascucd I. Ragni M. Russolillo E. Chiariello M. Experimental carotid stenosis and endothelial injury in the rabbit: an in vivo model to study intravascular platelet aggregation. Thromb Haemostas. 1992:67:302-305.
24. Roux S, Carteaux JP. Hess P. Favilene L, Clozel JP. Experimental carotid thrombosis in the guinea pig. Thromb Haemostas. 1994;71:252-256.
25. Clowes AW, Collazo RE. Karnovsky MJ. A morphologic and permeability study of luminal smooth muscle cells after arterial injury in the rat. Lab Invest. 1978;39:141-150.
26. Fishman JA. Ryan GB. Karnovsky MJ. Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest. 1975;32:339-351.
27. Schwartz SM. Stemerman MB. Benditt EP. The aortic intima. II. Repair of the aortic lining after mechanical denudation. AM J Pathol. 1975:81:15-42.
28. Reidy MA. A reassessment of endothelial injury and arterial lesion formation. Lab Invest. 1985;53:513-520.
29. Reimers HJ, Packham MA, Kinlough-Rathbone RL, Mustard JF. Effect of repeated treatment of rabbit platelets with low concentrations of thrombin on their function, metabolism and survival. Brit. J Haematol. 1973;25:675-689.
30. Owen WG. Bichler J. Erickson D, Wysokinski W. Gating of platelet function by p02-linkcd lowering of extra-cellular [Ca2+J. Biochemistry. 1995;34:9277-9281.
31. Romson JL, Haack DW, Lucchesi BR. Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of antithrombotic agents. Thromb Res. 1980:17:841-853.
32. Kordenat RK. Kezdi P, Stanley EL. A new catheter technique for producing experimental coronary thrombosis and selective coronary visualization. Amer. Heart J. 1972: 83:360-364.
33. Kiss RG. Lu HR, Roskams T. Jang IK, Plow EF, Gold HK. Collen D. Time course of the effects of a single bolus injection of F(ab')2 fragments of the antiplatelet GPlIb/IIIa antibody 7E3 on arterial eversion graft occlusion, platelet aggregation, and bleeding time in dogs. Arterioscler Thromb. 1994;14:367-374.
34. Kiss RG, Stassen JM. Dcckmyn H. Roskams T. Gold HK. Collen D. Contribution of platelets and the vessel wall to the antithrombotic effects of a single bolus injection of Fab fragments of the antiplatelet GPIIb/IIla antibody 7E3 in a canine arterial eversion graft preparation. Arterioscler Thromb. 1994:14:375-380.
35. Gold HK. Yasuda T, Ik-Kyung Jang, Guerrero JL, Fallon JT. Leinbach RC. Collen D. Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus. Circulation. 1991;83[suppl. IV]:IV-26-IV-40.
36. Shebuski RJ, Storer BL, Fujita T. Effect of thromboxane synthase inhibition on the thrombolytic action of tissue-type plasminogen activator in a rabbit model of peripheral arterial thrombosis. Thromb Res. 1988;52:381-392.
37. Shebuski RJ. Berry DE, Bennett DB. Romoff T. Storer BL. Qli F, Samanen J. Demonstration oi Ac-Arg-Giy-Asp-Ser-NH2 as an antiaggregation agent in the dog by intracoronary administration. Thromb Haemostas. 1989:61:183-188.
38. Kovacs IB, Tigyi-Sebes A. Trombistas K. Gorog R Evan’s blue: an ideal energy-absorbing material to produce intravascular microinjury by He-Ne gas laser. Microvasc Res. 1975;10:107-124.
39. Yamamoto J. Ishii I. Sasaki Y, Nagamatsu Y. Matsuda T, Anda E. Antithrombotic effect of Ticlopidine on He-Ne Laser-induced thrombus formation in rat mesenteric microvessels. Haemostasis. 1992:22:147-152.
40. Weichert W, Pauliks V, Breddin HK. Laser-induced thrombi in rat mesenteric vessels and anti thrombotic drugs. Haemostasis. 1983:13:61-71.
41. Boulnois JL. Photophysical processes in recent medical laser developments: a review. Lasers Med. Sc. 1985:1:47-66.
42. Seiffge D. Wcithmann K.U. Surprising effects of the sequential administration of pentoxyfilline and low dose acetyl salicylic acid on thrombus formation. Thromb. Res. 1987; 46:371-383.
43. Hovig T, McKenzie FN. Arfors KE. Measurement of the platelet response to laser-induced microvascular injury. Ultrastructural studies. Thrombos. Diathes. Haemorrh. (Stuttg.). 1974:32:695-703.
44. Arfors KE, Dhall DP. Engeset J, Hint H, Matheson NA, Tangen O. Biolaser endothelial trauma as means of quantifying platelet activity in vivo. Nature, London. 1987;218:887-888.
45. Van der Zypen E. England C. Fankhauser F. Kwasnievka S. Blood flow stasis induced by cw-Nd: YAG laser irradiation: comparative morphology of mesenteric and choroidal vessels in pigmented rabbits. Thromb. Haemost.; 1991: 65: 87-95.
46. Drouet L, Godard B, Gebrane-younes J, Pignaud G, Chameroy V. In vivo effects of a dye pulsed laser on microcirculation, in Biology and Pathology of platelet-vessel wall interactions. (Eds. G. Jolles) Academic Press. New York. 1987 pp351-373.
47. Bourgain RH. Vermarien H. Andries R. Vereecke F. Jacqueloot J, Rennies J, Blocked E, Six F. A standardized in vivo model for the study of experimental arterial thrombosis. Description of a method. Adv. Exp. Med. Biol. 1984;180:635-650.
48. Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc. Res. 1973;5:167-179.
49. Badimon L, Turitto V. Rosemark JA. Badimon JJ, Fuster V. Characterization of tubular flow chamber for studying platelet interaction with biologic and prosthetic materials: deposition of Indium 111-labeled platelets on collagen, sub-endothelium, and expanded polytetrafluoroethylene. J Lab Clin. Med. 1987:110:706-718.
50. Muggli R, Baumgartner HR. Tschopp TB, Keller H. Automated microdensitometry and protein assays as a measure for platelet adhesion and aggregation on collagen-coated slides under controlled flow conditions. J Lab Clin Med. 1980;95:195-207.
51. Sakariassen KS, Aarts PAMM. de Groot PG, Houdijk WPM, Sixma JJ. A peifusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extra-cellular matrix, and purified components. J Lab Clin Med. 1983;102:522-535.
52. Kirchhofer D. Tschopp TB. Steiner B, Baumgartner HR. Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood. Blood. 1995;86:3815-3822.
53. Orvim U. Barstad MR, Vlasuk GP, Sakariassen KS. Effect of selective factor Xa inhibition on arterial thrombus formation triggered by tissue factor/factor Vila or collagen in an ex vivo model of shear-dependent human thrombogenesis. Arterioscier Thromb. 1995;15:2188-2194.
54. André P, Arbeille B. Drouet V, Hainaud P. Bal Dit Sollier C, Caen JP. Drouet LO. Optimal antagonism of GPIlb/IIIa favors platelet adhesion by inhibiting thrombus growth: an ex-vivo capillary perfusion chamber study in the guinea pig. Arterioscier Thromb. Vase. Biol. 1996;16:56-63.
55. Hanson SR. Paxton LD, Harker LA. Iliac artery mural thrombus formation: Effect of antiplatelet therapy on 111 In-platelet deposition in baboons. Arteriosclerosis. 1986;6:511-518.
56. Hanson SR, Harker LA. Ruggeri ZM. Zimmerman T. Anti-platelet GPIlb/IIIa antibody (LJ-CP8) prevents thrombus formation and occlusion of small caliber vascular grafts. Circulation (suppl). 1986:74:11-236.
57. Hanson SR. Kotze HF, Savage B, Harker LA. Platelet interactions with dacron vascular grafts. Arteriosclerosis. 1985:5:595-603.
58. Cadroy Y, Horbctt TA, Hanson SR. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo. J Lab Clin Med. 1989;113:436-448.